The 350k you are referring to is on the 2nd page of the quarterly cash report. They aren't completely strapped for cash but obviously its low enough to deter buying, and yes, the share price is subject to a bit of a panic at the moment. I don't see any reason for this, nothing has changed, no bad news. I've been toying with the idea of topping up also. Like you say, we should see soon enough where we stand.
- Forums
- ASX - By Stock
- ARV
- looking good
looking good, page-34
Featured News
Add ARV (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $19.16M |
Open | High | Low | Value | Volume |
0.9¢ | 1.0¢ | 0.8¢ | $23.79K | 2.642M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 1258906 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.0¢ | 1297096 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 1258906 | 0.008 |
5 | 780000 | 0.007 |
1 | 250000 | 0.006 |
3 | 3400000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.010 | 1297096 | 4 |
0.011 | 5318736 | 11 |
0.012 | 894058 | 5 |
0.013 | 972271 | 4 |
0.014 | 646916 | 1 |
Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
Featured News
MND
Albemarle lithium downsize burns $200M hole in Monadelphous's pocket as latter's contracts terminated
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
ARV (ASX) Chart |